Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Preclinical Development of Non-Edited CD7 CAR-Modified Invariant NKT Cell Therapy for T-Cell Malignancies and Acute Myeloid Leukemia

Xianzheng Zhou

Blood (2022) 140 (Supplement 1): 7417–7418.

https://doi.org/10.1182/blood-2022-166611

Published: 2022

Journal Articles

Trispecific Killer Engagers (TriKEs) that contain IL-15 to make NK cells antigen specific and to sustain their persistence and expansion

Jeffrey S. Miller, MD, Martin Felice, Ron McElmurry, Valerie McCullar, Xianzheng Zhou, Jakub Tolar, MD PhD, Joerg Uwe Schmohl, Angela Panoskaltsis-Mortari, PhD, Bin Zhang, Elizabeth Taras, Michael R. Verneris, MD, Sarah Cooley, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Dan Vallera, PhD

Blood (2015) 126 (23): 232.

https://doi.org/10.1182/blood.V126.23.232.232

Published: 2015

Journal Articles

Mir-146a and Mir-146b Regulate Human Dendritic Cell Apoptosis and Cytokine Production By Targeting of TRAF6 and IRAK1

Haein Park, PhD, Xin Huang, MD, Changming Lu, PhD, Mitchell S. Cairo, MD, Xianzheng Zhou, MD PhD

Blood (2014) 124 (21): 4118.

https://doi.org/10.1182/blood.V124.21.4118.4118

Published: 2014

Journal Articles

Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Significantly Mediate Burkitt Lymphoma (BL) Regression and Improve Survival In Human BL Xenografted NSG Mice

Yaya Chu, PhD, Ashlin Yahr, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, Xianzheng Zhou, MD, PhD, Mitchell S. Cairo, MD

Blood (2013) 122 (21): 3263.

https://doi.org/10.1182/blood.V122.21.3263.3263

Published: 2013

Journal Articles

Expanded Natural Killer (NK) Cells Transfected with Anti-CD20 Chimeric Antigen Receptor (CAR) mRNA Have Significant Cytotoxicity Against Poor Risk B-Cell (CD20 + ) Leukemia/Lymphoma (B-L/L).

Yaya Chu, PhD, Janet Ayello, MS, MT(ASCP), Lowrence Lo, Jared Katz, Ashlin Yahr, Jessica Hochberg, MD, Carmella van de Ven, MA, Xianzheng Zhou, MD, PhD, Mitchell S. Cairo, MD

Blood (2012) 120 (21): 3007.

https://doi.org/10.1182/blood.V120.21.3007.3007

Published: 2012

Journal Articles

miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27 kip1 , KPC1 , and SOCS-1

Changming Lu, Xin Huang, Xiaoxiao Zhang, Kristin Roensch, Qing Cao, Keiichi I. Nakayama, Bruce R. Blazar, Yan Zeng, Xianzheng Zhou

Blood (2011) 117 (16): 4293–4303.

https://doi.org/10.1182/blood-2010-12-322503

Published: 2011

Includes: Supplemental data

Journal Articles

Stable gene transfer and expression in cord blood–derived CD34 + hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system

Xingkui Xue, Xin Huang, Sonja E. Nodland, Lajos Mátés, Linan Ma, Zsuzsanna Izsvák, Zoltán Ivics, Tucker W. LeBien, R. Scott McIvor, John E. Wagner, Xianzheng Zhou

Blood (2009) 114 (7): 1319–1330.

https://doi.org/10.1182/blood-2009-03-210005

Published: 2009

Includes: Supplemental data

Journal Articles

Sleeping Beauty (SB) Transposon Mediated Umbilical Cord Blood (UCB) T Cell Therapy for Refractory Acute Lymphoblastic Leukemia (ALL).

Xianzheng Zhou, MD, PhD, Xin Huang, MD, Johnthomas Kang, PhD, Hongfeng Guo, MD, PhD, Suet Choi, Preetinder Bassi, Tom C. Zhou, Michael C. Milone, MD, PhD, Bruce L. Levine, PhD, Carl H. June, MD, R. Scott McIvor, PhD, John E. Wagner, MD, Bruce R. Blazar, MD

Blood (2006) 108 (11): 722.

https://doi.org/10.1182/blood.V108.11.722.722

Published: 2006

Journal Articles

Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system

Xin Huang, Andrew C. Wilber, Lei Bao, Dong Tuong, Jakub Tolar, Paul J. Orchard, Bruce L. Levine, Carl H. June, R. Scott McIvor, Bruce R. Blazar, Xianzheng Zhou

Blood (2006) 107 (2): 483–491.

https://doi.org/10.1182/blood-2005-05-2133

Published: 2006

Journal Articles

Stable Gene Transfer and Expression in Human Primary T-Cells by the Sleeping Beauty Transposon System.

Xianzheng Zhou, MD, PhD, Xin Huang, MD, Andrew C. Wilber, PhD, Lei Bao, MD, PhD, Dong Tuong, BA, Jakub Tolar, MD, PhD, Paul J. Orchard, MD, Bruce L. Levine, PhD, Carl H. June, MD, Scott McIvor, PhD, Bruce R. Blazar, MD

Blood (2005) 106 (11): 5539.

https://doi.org/10.1182/blood.V106.11.5539.5539

Published: 2005

NARROW

Preclinical Development of Non-Edited CD7 CAR-Modified Invariant NKT Cell Therapy for T-Cell Malignancies and Acute Myeloid Leukemia

Trispecific Killer Engagers (TriKEs) that contain IL-15 to make NK cells antigen specific and to sustain their persistence and expansion

Mir-146a and Mir-146b Regulate Human Dendritic Cell Apoptosis and Cytokine Production By Targeting of TRAF6 and IRAK1

Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Significantly Mediate Burkitt Lymphoma (BL) Regression and Improve Survival In Human BL Xenografted NSG Mice

Expanded Natural Killer (NK) Cells Transfected with Anti-CD20 Chimeric Antigen Receptor (CAR) mRNA Have Significant Cytotoxicity Against Poor Risk B-Cell (CD20 + ) Leukemia/Lymphoma (B-L/L).

miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27 kip1 , KPC1 , and SOCS-1

Stable gene transfer and expression in cord blood–derived CD34 + hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system

Sleeping Beauty (SB) Transposon Mediated Umbilical Cord Blood (UCB) T Cell Therapy for Refractory Acute Lymphoblastic Leukemia (ALL).

Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system

Stable Gene Transfer and Expression in Human Primary T-Cells by the Sleeping Beauty Transposon System.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only